MoneyWorks4Me

Hester Biosciences posts 30% sales growth in Q4

07 May 2019 Evaluate

Hester Biosciences has registered 30% sales growth at Rs 48.83 crore in Q4FY19 as against Rs 37.48 crore in the same period of the previous year. Sales for the FY19 also increased 27% at Rs 171.19 crore as compared to Rs 135.25 crore in FY18.

Hester Biosciences is engaged in the manufacturing of poultry vaccines.

Peers
Company Name CMP
Sun Pharma. Inds. 1748.90
Dr. Reddys Labs. 1214.10
Cipla 1312.85
Lupin 1954.80
Zydus Lifesciences 1124.00
View more..